Full spectrum allergic rhinitis symptom relief (in a single device)
Dymista® treats all symptoms of seasonal and perennial allergies more effectively than any other single pharmacotherapy
Dymista® leads to greater symptom improvement than using either azelastine or fluticasone propionate alone.1
Dymista® provides substantial symptom relief from all symptoms of allergic rhinitis1 in a single device. This Is important as many allergic rhinitis patients continue to experience symptoms, even those taking treatments.2 In a survey of 1000 patients with seasonal allergic rhinitis in the UK, 70.5% of those with moderate/severe symptoms were taking at least two allergic rhinitis medications.3
Providing full spectrum symptom relief in a single device helps improve compliance and adherence with the medication, which could help improve the quality of life of allergic rhinitis patients.
Table 1. Shows pharmacotherapy effects on individual rhinitis symptoms adapted from scadding et al. 2017
Further Your Understanding
Click on one of the below links to discover more information about Dymista®, including Flow to use Dymista®, guidelines, clinical papers and request materials.
-
Allergic Rhinitis -
Impact of Rhinitis -
Onset -
Treatment -
Guidelines -
Clinical Papers
References
- Scadding GK, el al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017, First edition 2007). Clin Exp Allergy 2017; 47(7): 856-889.
- Lipworth B, et al. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel. NPJ Prim Care Respir Med. 2017; 27(1)
Want to expand your knowledge…
Register to ViatrisConnect and subscribe to our Allergy newsletters to continue reading.
Viatris Connect is an online platform for healthcare professionals. Register today and enjoy this article and a selection of others for free.
REGISTER NOW